Since April 22, 2025, 503A enforcement discretion ended, and the FDA proposed in April 2026 to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List
Free 15-minute consult, no obligation
Key examples include dienogest (DNG), a 19-nortestosterone derivative approved for endometriosis, which effectively reduces pain and lesion size with good tolerability and minimal impact on bone mineral density
It is medically supervised, biologically rational, supports hydration, requires no downtime and integrates naturally with the wider doctor-led wellness ecosystem vitamin therapy, NAD+ infusions, regenerative skin care that has matured in Dubai over the last few years
Sahni begins each weight loss journey with a thorough health assessment and a detailed discussion of your unique goals and lifestyle